Chronic Lymphocytic Leukemia Therapeutics Market Opportunity Analysis 2018- 2026 Health Articles | November 21 Wholesale Marshon Lattimore Jersey , 2018
High prevalence of CLL coupled with its high mortality rate, demonstrates the unmet market need for better therapeutics.
Chronic lymphocytic leukemia (CLL) is a most common type of leukemia found in adults. It is a kind of malignancy characterized by production of abnormal white blood cells in the bone marrow. Symptoms include, swelling of the lymph nodes, fatigue, fever, infection Wholesale Cameron Jordan Jersey , pain beneath the ribs, and weight loss. Although CLL is rarely seen in children and people under age 40, it is more prevalent in geriatric population. Moreover, causes of CLL are largely unknown and it is more severe than acute leukemia. The prevalence of CLL is high in males than females. Although, the incidence of this disorder is higher in white population than Asian populations, the precise cause for this cannot be explained.
Click To Continue Reading on Chronic Lymphocytic Leukemia Therapeutics Market
The diagnosis of CLL includes Blood Cell Count and Examination Wholesale Michael Thomas Jersey , Bone Marrow Examination for patients followed by treatment. The treatment includes single or combination drug therapy, targeted therapies, monoclonal antibody therapies, white blood cell (neutrophil) growth factors. In addition to this, there are radiation therapy and splenectomy which are rarely used for the treatment.
According to the American Cancer Society (ACS) estimates, around 20 Wholesale Alvin Kamara Jersey ,110 new cases of chronic lymphocytic leukemia and 4,660 deaths from CLL is expected in year 2017 in U.S. Furthermore, high prevalence of CLL in geriatric population is expected to increase demand for chronic lymphocytic leukemia therapeutics. According to the United Nations data, in 2015, around 901 million people in the world were over 60 years of age and this number is expected to reach 1.4 billion by 2030 and to 2.1 billion by 2050.
Furthermore, increasing number of incidences of comorbidities Wholesale Drew Brees Jersey , especially among geriatric population and launch of new pipeline drugs are major factors contributing to growth of the chronic lymphocytic leukemia therapeutics market. For instance, on December 8, 2015, Bendeka injection—manufactured under the collaboration of Teva Pharmaceuticals Industries Ltd. and Eagle Pharmaceuticals Inc. acquired approval from FDA for the treatment of patients with CLL and indolent B-cell non-Hodgkin lymphoma (NHL) — progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.
On the basis of region, the chronic lymphocytic leukemia therapeutics market is segmented into North America, Europe Wholesale Chauncey Gardner-Johnson Jersey , Latin America, Asia Pacific, Middle East, and Africa. North America accounted for the largest market share in 2016 due to the presence of breakthrough pipeline drugs. For instance, the drug Acalabrutinib—manufactured by Acerta Pharma BV—is under phase 2 clinical trial for the treatment of CLL and small lymphocytic lymphoma (SLL) and the study is expected to complete in January 2019
Request a sample copy of this report:
Key Vendors:
F. Hoffmann-La Roche Ltd, Novartis International AG Wholesale Erik McCoy Jersey , GlaxoSmithKline Pharmaceuticals Limited, Celgene Corporation, Genmab AS, Abbvie Inc. Teva Pharmaceutical Industries Ltd., Biogen Idec, AstraZeneca plc Wholesale Taysom Hill Jersey , Arno Therapeutics, Genzyme Corporation, Gilead Sciences INC., and others.
Contact Us:
Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1–206–701–6702 Email: sales@
Visit our news Website:
Article Tags: Chronic Lymphocytic Leukemia Cheap Rick Leonard Jersey , Lymphocytic Leukemia Therapeutics, Leukemia Therapeutics Market, Chronic Lymphocytic, Lymphocytic Leukemia, Leukemia Therapeutics, Therapeutics Market Cheap Tre'Quan Smith Jersey , Geriatric Population
For a lot of industries, the transmission of germs, viruses and bacteria during normal practice is a high risk function that is to be avoided at all costs. Medicine and the food and beverage industry along with cleaning and pharmaceutics are broad examples of these. For these industries operating conditions in theory have to be as sterile as possible to ensure that the highest standards of practice are maintained. In reality though this is not possible in all instances except when there is an extreme amount of monitoring of the working area. That is why a number of other subsidiary tools are implemented to raise the effectiveness of infection and germ barricading. The use of disposable vinyl gloves is one such practice that is widely employed to control the transmission of germs via tactile actions.
The use of disposable vinyl gloves in the work environment is extremely beneficial because it safeguards the wearer from coming into contact with any foreign agent and also at the same time protects others from the wearer if the wearer is infected. These gloves are generally made of high quality PVC which is a synthetic vinyl polymer and completely bereft of the allergen properties that are sometimes observed in the use of natural substances like latex in glove making. The use of disposable vinyl gloves is highly effective in areas like hospitals or kitchens where there is a liability of high frequency contact with multiple objects or people. What is best about this situation is that there is absolutely no loss of dexterity because the vinyl gives an almost bare skin feeling to the wearer.